RLMD logo

Relmada Therapeutics (RLMD) CAPEX

Annual CAPEX

N/A

December 31, 2023

Summary

Performance

1-Year Change

-

3-Year Change

-

5-Year Change

-

15-Year Change

-

RLMD CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1800.00
RLMD annual capital expenditures is currently at an all-time high

3-Year Low

-
RLMD annual capital expenditures 3-year low is unknown

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
RLMD previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 19, 2025
RLMD next annual earnings announcement is scheduled for Mar 19, 2025

OtherRLMDcash flowmetrics:

Annual FCF

-$51.66 M
RLMD annual free cash flow is -$51.66 million

Annual CFO

-$51.66 M
RLMD annual cash flow from operations is -$51.66 million

Annual CFI

$50.45 M
RLMD annual cash flow from investing activities is $50.45 million

Annual CFF

-$98.50 K
RLMD annual cash flow from financing activities is -$98.50 thousand

Quarterly CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

RLMD Quarterly CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1800.00
RLMD quarterly capital expenditures is currently at an all-time high

3-Year Low

-
RLMD quarterly capital expenditures 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RLMD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 19, 2025
RLMD next earnings announcement is scheduled for Mar 19, 2025

OtherRLMDcash flowmetrics:

Quarterly FCF

-$16.66 M
RLMD quarterly free cash flow is -$16.66 million

Quarterly CFO

-$16.66 M
RLMD quarterly cash flow from operations is -$16.66 million

Quarterly CFI

$16.14 M
RLMD quarterly cash flow from investing activities is $16.14 million

Quarterly CFF

-$89.60 K
RLMD quarterly cash flow from financing activities is -$89.60 thousand

TTM CAPEX

N/A

September 30, 2024

Summary

Performance

3-Month Change

-

1-Year Change

-

3-Year Change

-

5-Year Change

-

RLMD TTM CAPEX Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

All-time High

$1800.00
RLMD TTM capital expenditures is currently at an all-time high

3-Year Low

-
RLMD TTM capital expenditures 3-year low is unknown

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
RLMD previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Mar 19, 2025
RLMD next earnings announcement is scheduled for Mar 19, 2025

OtherRLMDcash flowmetrics:

TTM FCF

-$53.21 M
RLMD TTM free cash flow is -$53.21 million

TTM CFO

-$53.21 M
RLMD TTM cash flow from operations is -$53.21 million

TTM CFI

$47.96 M
RLMD TTM cash flow from investing activities is $47.96 million

TTM CFF

$33.60 K
RLMD TTM cash flow from financing activities is $33.60 thousand

RLMD CAPEX Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year---
3 y3 years---
5 y5 years---

RLMD CAPEX Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year
5 y5-year
alltimeall time

Relmada Therapeutics CAPEX History

DateAnnualQuarterlyTTM
Aug 2013
$1800.00
$0.00(-100.0%)
$1800.00(0.0%)
DateAnnualQuarterlyTTM
May 2013
-
$1800.00
$1800.00

FAQ

  • What is the all time high annual CAPEX for Relmada Therapeutics?
  • What is the all time high quarterly CAPEX for Relmada Therapeutics?
  • What is the all time high TTM CAPEX for Relmada Therapeutics?

What is the all time high annual CAPEX for Relmada Therapeutics?

Relmada Therapeutics all-time high annual capital expenditures is $1800.00

What is the all time high quarterly CAPEX for Relmada Therapeutics?

Relmada Therapeutics all-time high quarterly capital expenditures is $1800.00

What is the all time high TTM CAPEX for Relmada Therapeutics?

Relmada Therapeutics all-time high TTM capital expenditures is $1800.00